Genesis Pharmaceuticals Enterprises reported that Q1 (ended September 30, 2008) revenues climbed an admirable 66% to $27.6 million, and gross profit rose an even more dramatic 81% to $21.8 million. On a non-GAAP basis, Genesis reported net income of $4.8 million a 50% increase. On a GAAP basis, however, the situation was not as positive. Using those standards, net income for Q1 dipped slightly from $3.2 million last year to $3.1 million this year. More details...
Stock Symbol: (OTCBB: GNPH)